315 related articles for article (PubMed ID: 23752189)
1. Phospholipase D (PLD) drives cell invasion, tumor growth and metastasis in a human breast cancer xenograph model.
Henkels KM; Boivin GP; Dudley ES; Berberich SJ; Gomez-Cambronero J
Oncogene; 2013 Dec; 32(49):5551-62. PubMed ID: 23752189
[TBL] [Abstract][Full Text] [Related]
2. Serum deprivation confers the MDA-MB-231 breast cancer line with an EGFR/JAK3/PLD2 system that maximizes cancer cell invasion.
Ye Q; Kantonen S; Gomez-Cambronero J
J Mol Biol; 2013 Feb; 425(4):755-66. PubMed ID: 23238254
[TBL] [Abstract][Full Text] [Related]
3. The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.
Stricker HM; Rommerswinkel N; Keil S; Gnoth SA; Niggemann B; Dittmar T
Cell Commun Signal; 2021 Apr; 19(1):43. PubMed ID: 33832505
[TBL] [Abstract][Full Text] [Related]
4. Cell invasion of highly metastatic MTLn3 cancer cells is dependent on phospholipase D2 (PLD2) and Janus kinase 3 (JAK3).
Henkels KM; Farkaly T; Mahankali M; Segall JE; Gomez-Cambronero J
J Mol Biol; 2011 May; 408(5):850-62. PubMed ID: 21414324
[TBL] [Abstract][Full Text] [Related]
5. PLD-Specific Small-Molecule Inhibitors Decrease Tumor-Associated Macrophages and Neutrophils Infiltration in Breast Tumors and Lung and Liver Metastases.
Henkels KM; Muppani NR; Gomez-Cambronero J
PLoS One; 2016; 11(11):e0166553. PubMed ID: 27851813
[TBL] [Abstract][Full Text] [Related]
6. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells.
Kang DW; Park MH; Lee YJ; Kim HS; Lindsley CW; Alex Brown H; Min do S
Int J Cancer; 2011 Feb; 128(4):805-16. PubMed ID: 20473892
[TBL] [Abstract][Full Text] [Related]
7. Two sites of action for PLD2 inhibitors: The enzyme catalytic center and an allosteric, phosphoinositide biding pocket.
Ganesan R; Mahankali M; Alter G; Gomez-Cambronero J
Biochim Biophys Acta; 2015 Mar; 1851(3):261-72. PubMed ID: 25532944
[TBL] [Abstract][Full Text] [Related]
8. The transcription factors Slug (SNAI2) and Snail (SNAI1) regulate phospholipase D (PLD) promoter in opposite ways towards cancer cell invasion.
Ganesan R; Mallets E; Gomez-Cambronero J
Mol Oncol; 2016 May; 10(5):663-76. PubMed ID: 26781944
[TBL] [Abstract][Full Text] [Related]
9. Binding of PLD2-Generated Phosphatidic Acid to KIF5B Promotes MT1-MMP Surface Trafficking and Lung Metastasis of Mouse Breast Cancer Cells.
Wang Z; Zhang F; He J; Wu P; Tay LWR; Cai M; Nian W; Weng Y; Qin L; Chang JT; McIntire LB; Di Paolo G; Xu J; Peng J; Du G
Dev Cell; 2017 Oct; 43(2):186-197.e7. PubMed ID: 29033361
[TBL] [Abstract][Full Text] [Related]
10. Role of phospholipase D in migration and invasion induced by linoleic acid in breast cancer cells.
Diaz-Aragon R; Ramirez-Ricardo J; Cortes-Reynosa P; Simoni-Nieves A; Gomez-Quiroz LE; Perez Salazar E
Mol Cell Biochem; 2019 Jul; 457(1-2):119-132. PubMed ID: 30877512
[TBL] [Abstract][Full Text] [Related]
11. A new signaling pathway (JAK-Fes-phospholipase D) that is enhanced in highly proliferative breast cancer cells.
Ye Q; Kantonen S; Henkels KM; Gomez-Cambronero J
J Biol Chem; 2013 Apr; 288(14):9881-9891. PubMed ID: 23404507
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidic Acid Increases Epidermal Growth Factor Receptor Expression by Stabilizing mRNA Decay and by Inhibiting Lysosomal and Proteasomal Degradation of the Internalized Receptor.
Hatton N; Lintz E; Mahankali M; Henkels KM; Gomez-Cambronero J
Mol Cell Biol; 2015 Sep; 35(18):3131-44. PubMed ID: 26124282
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitor.
Lavieri RR; Scott SA; Selvy PE; Kim K; Jadhav S; Morrison RD; Daniels JS; Brown HA; Lindsley CW
J Med Chem; 2010 Sep; 53(18):6706-19. PubMed ID: 20735042
[TBL] [Abstract][Full Text] [Related]
14. Effects of active and inactive phospholipase D2 on signal transduction, adhesion, migration, invasion, and metastasis in EL4 lymphoma cells.
Knoepp SM; Chahal MS; Xie Y; Zhang Z; Brauner DJ; Hallman MA; Robinson SA; Han S; Imai M; Tomlinson S; Meier KE
Mol Pharmacol; 2008 Sep; 74(3):574-84. PubMed ID: 18523140
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin.
Kandori S; Kojima T; Matsuoka T; Yoshino T; Sugiyama A; Nakamura E; Shimazui T; Funakoshi Y; Kanaho Y; Nishiyama H
Cancer Sci; 2018 Jun; 109(6):1865-1875. PubMed ID: 29660846
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of MicroRNAs (MiRs) 203, 887, 3619 and 182 Prevents Vimentin-triggered, Phospholipase D (PLD)-mediated Cancer Cell Invasion.
Fite K; Gomez-Cambronero J
J Biol Chem; 2016 Jan; 291(2):719-30. PubMed ID: 26567912
[TBL] [Abstract][Full Text] [Related]
17. Phospholipase D in cell signaling: from a myriad of cell functions to cancer growth and metastasis.
Gomez-Cambronero J
J Biol Chem; 2014 Aug; 289(33):22557-22566. PubMed ID: 24990944
[TBL] [Abstract][Full Text] [Related]
18. Proliferative and metastatic roles for Phospholipase D in mouse models of cancer.
Roth E; Frohman MA
Adv Biol Regul; 2018 Jan; 67():134-140. PubMed ID: 29154090
[TBL] [Abstract][Full Text] [Related]
19. The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).
Gomez-Cambronero J
Cell Signal; 2011 Dec; 23(12):1885-95. PubMed ID: 21740967
[TBL] [Abstract][Full Text] [Related]
20. SCD1 activity promotes cell migration via a PLD-mTOR pathway in the MDA-MB-231 triple-negative breast cancer cell line.
Lingrand M; Lalonde S; Jutras-Carignan A; Bergeron KF; Rassart E; Mounier C
Breast Cancer; 2020 Jul; 27(4):594-606. PubMed ID: 31993937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
